Price Vision Group BlogTHE LATEST NEWS FROM PRICE VISION GROUP
SAN DIEGO–(BUSINESS WIRE)–Trefoil Therapeutics today announced it has initiated the first clinical trial of its engineered Fibroblast Growth Factor-1 TTHX1114 for the treatment of people with corneal endothelial dystrophies (CED), including Fuchs Endothelial Corneal Dystrophy. To read the full press release, please click here.
Our Indianapolis location on North Meridian Street offers a modern, comfortable environment designed with your care and convenience in mind. The Price Vision Group facility sits in a professional medical complex that's easily identifiable by its contemporary architectural design and well-maintained landscape. We see patients from Indiana cities including Zionsville, Fishers, Carmel, Noblesville, Avon, and Greenwood, as well as people who travel from across the U.S. and even abroad for treatment by our renowned physicians.
Once inside, you'll find a welcoming reception area with ample seating and a patient-focused layout that minimizes wait times. Our surgical suite houses the latest diagnostic and treatment technology, ensuring you receive the most advanced care available.
Price Vision Group
9002 N Meridian St #100, Indianapolis, IN 46260
(317) 844-5530
